Keyword: European Medicines Agency (EMA)

News

GSK Combined Melanoma Treatment Delayed in Europe

28.03.2014 - GlaxoSmithKline (GSK), the UK's largest pharmaceutical company, has provisionally withdrawn its marketing authorization application to the European Medicines Agency (EMA) for the...

News

EU Looks to Speed Drug Access With Staggered Approval

20.03.2014 - The European Medicines Agency, EMA, has said it will try out a new process of staggered drug approvals in a bid to accelerate access to new medicines. The decision to pilot so...

News

Ending Drug Trial Secrecy Is a Boon for R&D, Says EU Agency

22.10.2013 - Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug...

Plant Construction & Process Technology

Enzymes as a Catalytic All Rounder

10.09.2013 - The Perfect Storm - More and more chemical and pharmaceutical companies are recognizing the need to make their processes more environmentally sustainable, a trend that is right at...

Plant Construction & Process Technology

GDUFA’s Impact on the API Industry

06.08.2013 - One-Time Fee - On Oct. 1, 2012, the U. S. Food and Drug Administration (FDA) implemented the long-discussed Generic Drug User Fee Act (GDUFA) , thereby authorizing the agency to...

News

Europe Backs New Dual-Action Novartis Lung Drug

29.07.2013 - Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro...

News

Sanofi’s Chris Viehbacher: EU’s Drug Data Stance Threatens Investment

25.06.2013 - The European Medicines Agency's (EMA) decision to release detailed data on drugs once a medicine is approved could discourage critical investment in crisis-hit Europe, Sanofi's...

News

Court Stops EU Regulator Releasing Drug Company Data

30.04.2013 - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favouring the two U.S. companies...